Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Christophe Le Tourneau(Inserm), James L. Gulley(National Institutes of Health)
Cited by 165
Related Papers
Dose Escalation Methods in Phase I Cancer Clinical Trials
|JNCI Journal of the National Cancer Institute|2009|856
Immune gene expression in head and neck squamous cell carcinoma patients
|European Journal of Cancer|2019|64